Marcelle S. Balcombe
Partner

Introduction
Marcelle S. Balcombe is a member of the Corporate and Securities practice group of Sichenzia Ross Ference Carmel LLP.
Marcelle advises clients in connection with corporate finance transactions, mergers and acquisitions and securities law matters including initial public offerings, secondary offerings, shelf registrations, ATM offerings, private investments in public equity (PIPEs), registered direct transactions, going private transactions and other securities offerings. Marcelle also advises on reverse merger transactions. She has experience representing both purchasers and sellers in connection with stock purchases, asset purchases and merger transactions, including the negotiation of stock and asset purchase agreements, merger agreements, letters of intent, confidentiality agreements and other related documents.
Marcelle has extensive experience performing legal and financial due diligence, drafting documentation and conducting negotiations in connection with corporate finance transactions, both public and private offerings, mergers and acquisitions and other strategic transactions. She advises issuers in the preparation of legal documentation for day-to-day operations, including general contracts, employment agreements and compensation plans. She also provides ongoing counsel to issuers regarding securities law compliance, corporate governance, corporate law compliance and regulatory inquiries. Marcelle also advises clients seeking to list on the major US stock exchanges, including NASDAQ and NYSE. She also advises on corporate governance for publicly listed U.S. companies.

Education
Ms. Balcombe received her Juris Doctorate from Case Western Reserve University, School of Law.
Bar Admissons
Ms. Balcombe is admitted to practice in New York and New Jersey.
Practice Areas
Corporate law group
Mergers & Acquisitions
Legal Services for Entrepreneurs
Hedge Fund Formation
Capital Markets
Securities law group
Restricted Stock & Beneficial Ownership Filings
Registration Statements
Exchange Act Reporting & Compliance Matters
APOs & Reverse Mergers
Contact Address
Office: New York
Phone: (212) 930-9700
Direct dial: (646) 810-2184
Fax: (212) 930-9725